168 related articles for article (PubMed ID: 14978768)
21. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
[TBL] [Abstract][Full Text] [Related]
22. Differential characteristics of HIV-based versus SIV-based lentiviral vector systems: Gene delivery to neurons and axonal transport of expressed gene.
Kitagawa R; Miyachi S; Hanawa H; Takada M; Shimada T
Neurosci Res; 2007 Apr; 57(4):550-8. PubMed ID: 17275114
[TBL] [Abstract][Full Text] [Related]
23. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 replication by novel lentiviral vectors expressing transdominant Rev and HIV-1 env antisense.
Mautino MR; Morgan RA
Gene Ther; 2002 Apr; 9(7):421-31. PubMed ID: 11938457
[TBL] [Abstract][Full Text] [Related]
25. Transduction of human immunodeficiency virus type 1 vectors lacking encapsidation and dimerization signals.
Laham-Karam N; Bacharach E
J Virol; 2007 Oct; 81(19):10687-98. PubMed ID: 17652403
[TBL] [Abstract][Full Text] [Related]
26. A novel lentivirus vector derived from apathogenic simian immunodeficiency virus.
Stitz J; Mühlebach MD; Blömer U; Scherr M; Selbert M; Wehner P; Steidl S; Schmitt I; König R; Schweizer M; Cichutek K
Virology; 2001 Dec; 291(2):191-7. PubMed ID: 11878888
[TBL] [Abstract][Full Text] [Related]
27. Self-inactivating lentiviral vectors with U3 and U5 modifications.
Iwakuma T; Cui Y; Chang LJ
Virology; 1999 Aug; 261(1):120-32. PubMed ID: 10441560
[TBL] [Abstract][Full Text] [Related]
28. Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol.
Lu X; Humeau L; Slepushkin V; Binder G; Yu Q; Slepushkina T; Chen Z; Merling R; Davis B; Chang YN; Dropulic B
J Gene Med; 2004 Sep; 6(9):963-73. PubMed ID: 15352069
[TBL] [Abstract][Full Text] [Related]
29. Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
McKenna PM; Koser ML; Carlson KR; Montefiori DC; Letvin NL; Papaneri AB; Pomerantz RJ; Dietzschold B; Silvera P; McGettigan JP; Schnell MJ
J Infect Dis; 2007 Apr; 195(7):980-8. PubMed ID: 17330788
[TBL] [Abstract][Full Text] [Related]
30. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors.
Cockrell AS; Ma H; Fu K; McCown TJ; Kafri T
Mol Ther; 2006 Aug; 14(2):276-84. PubMed ID: 16516556
[TBL] [Abstract][Full Text] [Related]
31. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
32. Alleviation of murine leukemia virus repression in embryonic carcinoma cells by genetically engineered primer binding sites and artificial tRNA primers.
Modin C; Lund AH; Schmitz A; Duch M; Pedersen FS
Virology; 2000 Dec; 278(2):368-79. PubMed ID: 11118360
[TBL] [Abstract][Full Text] [Related]
33. Functional replacement of the R region of simian immunodeficiency virus-based vectors by heterologous elements.
Brandt S; Grunwald T; Lucke S; Stang A; Überla K
J Gen Virol; 2006 Aug; 87(Pt 8):2297-2307. PubMed ID: 16847126
[TBL] [Abstract][Full Text] [Related]
34. Induction of HIV-specific T and B cell responses with a replicating and conditionally infectious lentiviral vaccine.
Wingard JB; Anderson B; Weissman D
Eur J Immunol; 2008 May; 38(5):1310-20. PubMed ID: 18412164
[TBL] [Abstract][Full Text] [Related]
35. Sustained transgene expression by human cord blood derived CD34+ cells transduced with simian immunodeficiency virus agmTYO1-based vectors carrying the human coagulation factor VIII gene in NOD/SCID mice.
Kikuchi J; Mimuro J; Ogata K; Tabata T; Ueda Y; Ishiwata A; Kimura K; Takano K; Madoiwa S; Mizukami H; Hanazono Y; Kume A; Hasegawa M; Ozawa K; Sakata Y
J Gene Med; 2004 Oct; 6(10):1049-60. PubMed ID: 15386735
[TBL] [Abstract][Full Text] [Related]
36. Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus.
Schnell T; Foley P; Wirth M; Münch J; Uberla K
Hum Gene Ther; 2000 Feb; 11(3):439-47. PubMed ID: 10697118
[TBL] [Abstract][Full Text] [Related]
37. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
Xu W; Morrow CD
Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of simian immunodeficiency virus by foamy virus vectors expressing siRNAs.
Park J; Nadeau P; Zucali JR; Johnson CM; Mergia A
Virology; 2005 Dec; 343(2):275-82. PubMed ID: 16181654
[TBL] [Abstract][Full Text] [Related]
40. Analysis of human immunodeficiency virus type 1 vector cis- and trans-acting elements production by means of Semliki Forest virus.
Del Vecchio C; Calistri A; Lombardi G; Celegato M; Biasolo MA; Palù G; Parolin C
Gene Ther; 2009 Feb; 16(2):279-90. PubMed ID: 19037240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]